SCHEMBL6624710

SCHEMBL6624710

C[C@H]1OC(=O)[C@@H]2C[C@@H]3CCCC[C@H]3[C@H](C=Cc3ccc(-c4cccc(C(F)(F)F)c4)cn3)[C@H]12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
F2R P25116 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1106195 1.00 F2R (1.00) F2R
SCHEMBL12759520 0.91 F2R (0.85) F2R
SCHEMBL13324631 0.90 F2R (0.82) F2R
SCHEMBL12213245 0.90 F2R (1.00) F2R
SCHEMBL12831328 0.90 F2R (1.00) F2R
SCHEMBL14379735 0.90 F2R (1.00) F2R
SCHEMBL471257 0.90 F2R (1.00) F2R
SCHEMBL13324629 0.90 F2R (0.83) F2R
SCHEMBL13324630 0.90 F2R (0.83) F2R
SCHEMBL14375452 0.90 F2R (1.00) F2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8563511-B2 Treatment of pulmonary hypertension using an agent that inhibits a tissue factor pathway UNIVERSITY OF ROCHESTER (US) 2013-10-22 US disclosed
EP-1036072-B1 THROMBIN RECEPTOR ANTAGONISTS SCHERING CORP (US) 2004-05-06 EP disclosed
US-6326380-B1 CARDIOVASCULAR DISORDERS; ANTICANCER AGENTS SCHERING CORPORATION 2001-12-04 US disclosed